Brief: Emmaus Life Sciences Receives Notice Of Nasdaq Delisting Following Merger With Mynd Analytics
22/07/2019 21:23
July 22 (Reuters) - Emmaus Life Sciences Inc EMMA.O :
* EMMAUS LIFE SCIENCES RECEIVES NOTICE OF NASDAQ DELISTING
FOLLOWING MERGER WITH MYND ANALYTICS
* EMMAUS LIFE SCIENCES INC - EMMAUS TO APPEAL NASDAQ STAFF'S
DETERMINATION
Source text for Eikon: ID:nPn1ss54Ra
Further company coverage: EMMA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns